Universität zu Köln

Nanni, Cristina, Cottereau, Anne Segolene, Lopci, Egesta ORCID: 0000-0001-9732-1094, Bodet-Milin, Caroline ORCID: 0000-0002-8219-3592, Coronado, Monica, Pro, Barbara, Kim, Wong Seog, Trotman, Judith ORCID: 0000-0001-8009-4593, Barrington, Sally, Duhrsen, Ulrich, Vander Borght, Thierry, Zamagni, Elena ORCID: 0000-0003-1422-7305, Kraeber-Bodere, Francoise ORCID: 0000-0002-3417-0759, Messiou, Christina ORCID: 0000-0002-0557-9379, Rahmouni, Alain, Buvat, Irene ORCID: 0000-0002-7053-6471, Andre, Marc, Hertzberg, Mark, Oyen, Wim, Casasnovas, Olivier, Luminari, Stefano ORCID: 0000-0001-8446-2285, Garderet, Laurent, Montravers, Francoise, Kobe, Carsten, Kluge, Regine, Versari, Annibale ORCID: 0000-0002-8675-2435, Zucca, Emanuele ORCID: 0000-0002-5522-6109, Moreau, Philippe, Cheson, Bruce, Haioun, Corinne ORCID: 0000-0003-0095-5379, Gallamini, Andrea and Meignan, Michel (2017). Report of the 6th International Workshop on PET in lymphoma. Leuk. Lymphoma, 58 (10). S. 2298 - 2304. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Full text not available from this repository.

Abstract

Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Nanni, Cristina UNSPECIFIED UNSPECIFIED UNSPECIFIED Cottereau, Anne Segolene UNSPECIFIED UNSPECIFIED UNSPECIFIED Lopci, Egesta UNSPECIFIED orcid.org/0000-0001-9732-1094 UNSPECIFIED Bodet-Milin, Caroline UNSPECIFIED orcid.org/0000-0002-8219-3592 UNSPECIFIED Coronado, Monica UNSPECIFIED UNSPECIFIED UNSPECIFIED Pro, Barbara UNSPECIFIED UNSPECIFIED UNSPECIFIED Kim, Wong Seog UNSPECIFIED UNSPECIFIED UNSPECIFIED Trotman, Judith UNSPECIFIED orcid.org/0000-0001-8009-4593 UNSPECIFIED Barrington, Sally UNSPECIFIED UNSPECIFIED UNSPECIFIED Duhrsen, Ulrich UNSPECIFIED UNSPECIFIED UNSPECIFIED Vander Borght, Thierry UNSPECIFIED UNSPECIFIED UNSPECIFIED Zamagni, Elena UNSPECIFIED orcid.org/0000-0003-1422-7305 UNSPECIFIED Kraeber-Bodere, Francoise UNSPECIFIED orcid.org/0000-0002-3417-0759 UNSPECIFIED Messiou, Christina UNSPECIFIED orcid.org/0000-0002-0557-9379 UNSPECIFIED Rahmouni, Alain UNSPECIFIED UNSPECIFIED UNSPECIFIED Buvat, Irene UNSPECIFIED orcid.org/0000-0002-7053-6471 UNSPECIFIED Andre, Marc UNSPECIFIED UNSPECIFIED UNSPECIFIED Hertzberg, Mark UNSPECIFIED UNSPECIFIED UNSPECIFIED Oyen, Wim UNSPECIFIED UNSPECIFIED UNSPECIFIED Casasnovas, Olivier UNSPECIFIED UNSPECIFIED UNSPECIFIED Luminari, Stefano UNSPECIFIED orcid.org/0000-0001-8446-2285 UNSPECIFIED Garderet, Laurent UNSPECIFIED UNSPECIFIED UNSPECIFIED Montravers, Francoise UNSPECIFIED UNSPECIFIED UNSPECIFIED Kobe, Carsten UNSPECIFIED UNSPECIFIED UNSPECIFIED Kluge, Regine UNSPECIFIED UNSPECIFIED UNSPECIFIED Versari, Annibale UNSPECIFIED orcid.org/0000-0002-8675-2435 UNSPECIFIED Zucca, Emanuele UNSPECIFIED orcid.org/0000-0002-5522-6109 UNSPECIFIED Moreau, Philippe UNSPECIFIED UNSPECIFIED UNSPECIFIED Cheson, Bruce UNSPECIFIED UNSPECIFIED UNSPECIFIED Haioun, Corinne UNSPECIFIED orcid.org/0000-0003-0095-5379 UNSPECIFIED Gallamini, Andrea UNSPECIFIED UNSPECIFIED UNSPECIFIED Meignan, Michel UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-243712
DOI:	10.1080/10428194.2017.1298752
Journal or Publication Title:	Leuk. Lymphoma
Volume:	58
Number:	10
Page Range:	S. 2298 - 2304
Date:	2017
Publisher:	TAYLOR & FRANCIS LTD
Place of Publication:	ABINGDON
ISSN:	1029-2403
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology; Hematology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/24371